http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2144355-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8f70c5b59b293a0220e30a752bb017f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C403-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4433
filingDate 1997-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb42c50f460742e9daa9b8960f212a08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c57192497d9be5c6f34b86407ff6b5f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7e2ca34d46502aec0e0a40fa953ccb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5eeb8415f96bb50562a407652843a36d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c1f1356ae0a428eb90aa51a721924af
publicationDate 2000-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2144355-A1
titleOfInvention CHROME-DERIVED COMPOUNDS.
abstract Compounds derived from chromene of general formula (I) where R represents hydrogen, CHO, CH sub, 2 OR sub, 2, or COOH; R sub, 1 means hydrogen or CH sub, 2 OH; and R sub, 2 means alkyl whose carbon number is between 1 and 4, inclusive, with the proviso that a substituent chosen from R and R sub, 1 must be hydrogen, as well as their pharmaceutically acceptable salts. The process for their preparation and the pharmaceutical compositions that contain them are also described. These compounds are new and have application in the treatment of psychosis, schizophrenia and allergy.
priorityDate 1997-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0064255-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9632389-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0428437-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0402644-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0228893-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0613897-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2074966-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9525733-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0190015-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9823559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410215783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457834382
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394313

Total number of triples: 43.